Isotretinoin vs Doxycycline for Drug-Induced Acne

(PNOC039 Trial)

This trial explores whether isotretinoin (a form of vitamin A used as a medication) or doxycycline (an antibiotic) is more effective for treating acne-like rashes that appear after certain cancer treatments. These rashes, often on the face, scalp, upper chest, or back, can be uncomfortable and impact daily life. Individuals who develop this type of rash while undergoing cancer treatments targeting the MAPK cell pathway might be suitable candidates. Participants should not have used isotretinoin for at least six months or doxycycline for four weeks before joining. As a Phase 2 trial, this research focuses on assessing the treatment's effectiveness in an initial, smaller group of people.

The trial protocol does not specify if you must stop taking your current medications. However, if you have taken doxycycline or isotretinoin before, there are specific waiting periods before you can join the study: 4 weeks for doxycycline and 6 months for isotretinoin.

A previous study showed that isotretinoin significantly reduces acne, particularly the red, swollen spots. However, it can cause side effects such as headaches, blurred vision, and dizziness. Some individuals have also reported depression and mood changes, which are rare but serious. Monitoring for these side effects during treatment is important.

Conversely, doxycycline is generally gentler on the body. Research has shown it carries a lower risk of serious side effects. Common but mild side effects include an upset stomach and increased sensitivity to sunlight.

Researchers are excited about these treatments because they offer different approaches to managing drug-induced acne compared to traditional options like topical retinoids or benzoyl peroxide. Isotretinoin, known for treating severe acne, works by reducing oil production and inflammation, potentially offering a more robust solution for drug-induced cases. On the other hand, doxycycline, an antibiotic, addresses acne by tackling bacteria and inflammation, providing a potentially gentler option. These treatments may provide new alternatives for patients who haven't responded well to current standard therapies.

This trial will compare the effectiveness of isotretinoin and doxycycline for drug-induced acne. Studies have shown that isotretinoin, which participants in this trial may receive, ranks among the most effective treatments for severe acne, leading to long-term improvement in many patients. One study found that it can reduce acne by up to 84% over 20 weeks. Meanwhile, doxycycline, another treatment option in this trial, is an antibiotic that reduces bacteria and swelling linked to acne. Research shows that doxycycline works well for moderate to severe acne, although full effects may take a few weeks to appear. Both treatments have proven effective for acne, but isotretinoin is often recognized for its strong and lasting results.¹²⁶⁷⁸